Auxier Asset Management Gilead Sciences, Inc. Transaction History

Auxier Asset Management

$672 Million
Q3 2024

A detailed history of Auxier Asset Management transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Auxier Asset Management holds 11,777 shares of GILD stock, worth $1.09 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

11,777

Previous 11,825 0.41%

Holding current value

$1.09 Million

Previous $811,000 21.7%

% of portfolio

0.15%

Previous 0.13%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$66.59 - $83.99 $3,196 - $4,031	-48 Reduced 0.41%	11,777 $987,000
Q2 2024 Aug 13, 2024	SELL	$63.15 - $72.88 $631 - $728	-10 Reduced 0.08%	11,825 $811,000
Q1 2024 May 08, 2024	SELL	$71.58 - $87.29 $27,343 - $33,344	-382 Reduced 3.13%	11,835 $866,000
Q4 2023 Feb 22, 2024	SELL	$73.27 - $83.09 $26,816 - $30,410	-366 Reduced 2.91%	12,217 $989,000
Q3 2023 Nov 21, 2023	SELL	$73.94 - $80.67 $16,266 - $17,747	-220 Reduced 1.72%	12,583 $942,000
Q2 2023 Aug 17, 2023	SELL	$76.01 - $86.7 $2,660 - $3,034	-35 Reduced 0.27%	12,803 $986,000
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $28,604 - $32,589	-370 Reduced 2.8%	12,838 $1.07 Million
Q4 2022 Feb 17, 2023	SELL	$62.32 - $89.47 $1,869 - $2,684	-30 Reduced 0.23%	13,208 $1.13 Million
Q3 2022 Nov 15, 2022	SELL	$59.54 - $68.01 $4,167 - $4,760	-70 Reduced 0.53%	13,238 $817,000
Q1 2022 May 17, 2022	SELL	$57.92 - $72.58 $8,688 - $10,887	-150 Reduced 1.11%	13,308 $791,000
Q4 2021 Mar 01, 2022	SELL	$64.88 - $73.64 $31,791 - $36,083	-490 Reduced 3.51%	13,458 $977,000
Q2 2021 Aug 18, 2021	SELL	$63.47 - $69.35 $9,520 - $10,402	-150 Reduced 1.06%	13,948 $960,000
Q4 2020 Mar 05, 2021	SELL	$56.65 - $64.55 $76,760 - $87,465	-1,355 Reduced 8.77%	14,098 $821,000
Q3 2020 Mar 05, 2021	BUY	$62.1 - $78.08 $229,956 - $289,130	3,703 Added 31.51%	15,453 $976,000
Q2 2020 Aug 20, 2020	SELL	$72.34 - $84.0 $3,617 - $4,200	-50 Reduced 0.42%	11,750 $904,000
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $115,865 - $148,407	1,850 Added 18.59%	11,800 $882,000
Q4 2019 Feb 21, 2020	SELL	$61.62 - $67.78 $6,162 - $6,778	-100 Reduced 1.0%	9,950 $647,000
Q2 2019 Aug 15, 2019	SELL	$61.87 - $69.38 $110,128 - $123,496	-1,780 Reduced 15.05%	10,050 $679,000
Q1 2019 May 14, 2019	BUY	$62.53 - $70.05 $101,611 - $113,831	1,625 Added 15.92%	11,830 $769,000
Q4 2018 Feb 13, 2019	SELL	$60.54 - $79.0 $81,426 - $106,255	-1,345 Reduced 11.65%	10,205 $638,000
Q3 2018 Nov 19, 2018	BUY	$71.28 - $78.92 $219,186 - $242,679	3,075 Added 36.28%	11,550 $892,000
Q2 2018 Aug 15, 2018	BUY	$64.88 - $75.68 $6,488 - $7,568	100 Added 1.19%	8,475 $600,000
Q1 2018 May 14, 2018	BUY	$72.84 - $88.8 $6,919 - $8,436	95 Added 1.15%	8,375 $631,000
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $10,672 - $12,528	150 Added 1.85%	8,280 $593,000
Q3 2017 Nov 09, 2017	BUY	$72.11 - $85.47 $97,853 - $115,982	1,357 Added 20.04%	8,130 $659,000
Q2 2017 Aug 16, 2017	BUY	N/A	6,773	6,773 $479,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Auxier Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Auxier Asset Management with notifications on news.

Account

Auxier Asset Management Gilead Sciences, Inc. Transaction History